- Case report
- Open Access
Diagnostic dilemma in a case of malignant mixed mullerian tumor of the cervix
© Maheshwari et al; licensee BioMed Central Ltd. 2006
Received: 12 December 2005
Accepted: 01 July 2006
Published: 01 July 2006
Malignant mixed mullerian tumors (MMMT) are rare biphasic malignant neoplasm. The commonest site of their occurrence in female genital tract is body of the uterus. MMMT of the cervix is extremely rare.
We report the clinical, pathological and immunohistochemical profile and diagnostic difficulties in a case of giant MMMT of the cervix in a postmenopausal woman who presented with a large cervical mass. On microscopic examination, initially tumor appeared to be endometrial stromal sarcoma, however, immunohistochemical examination revealed the biphasic nature of the tumor. The malignant epithelial component was basaloid squamous carcinoma with homologous sarcomatous component. The patient was treated with surgery. However, she experienced vaginal vault recurrence four months after the initial treatment, which was successfully treated with pelvic radiotherapy.
Accurate diagnosis of cervical MMMT is important for appropriate treatment of the patient.
Malignant mixed mullerian tumors (MMMT) are rare biphasic malignant neoplasm. The commonest site of occurrence of female genital tract MMMT is the uterine corpus. MMMT of the cervix is extremely rare. It was first described by Ferriera in 1951 . Approximately 50 cases have been reported in the English language literature on this rare entity .
We report the clinical, pathological and immunohistochemical profile and diagnostic difficulties in a case of giant MMMT of the cervix where malignant epithelial component resembled endometrial stromal sarcoma.
A 60-year-old postmenopausal woman presented with lump in lower abdomen of 2 months duration. Abdominal examination revealed a large, irregular, firm supra-pubic mass. On pelvic examination, the same mass was felt in the vagina. Cervix and uterus were not felt separately from the mass. Computed tomography (CT) scan showed a large, well defined heterogeneous abdomino-pelvic mass. Serum CA-125 level was 52.3 U/mL. Exploratory laparotomy was performed, which revealed a large, bosselated mass arising from the cervix. Body of the uterus, bilateral ovaries, tubes and other abdomino-pelvic organs were within normal limits. Total abdominal hysterectomy with bilateral salpingo-oophorectomy with complete excision of the mass was done after identifying the ureters from pelvic brim to their entry into the urinary bladder. Her postoperative recovery was uneventful.
The patient was kept under close observation after initial treatment. Four months after surgery, on routine follow-up, vaginal cytology showed the malignant squamous component of MMMT. The recurrence was confirmed by colposcopy-guided biopsy from the vaginal vault. Physical examination and CT-scan did not reveal any evidence of disease elsewhere. This recurrence was treated with radical pelvic radiotherapy (RT) (external pelvic RT 60 Gy in 30 fractions plus 2 intracavitary applications of 6 Gy each). The patient is free of disease at eighteen months after the treatment of recurrence.
Gross examination of the surgical specimen revealed a 28 × 20 × 15 cm bosselated, mass arising from the cervix. The cervical canal was distorted because of the mass. On cut surface, the mass was fleshy, solid with cystic areas.
Cervical MMMT usually occur in post-menopausal women with mean age at diagnosis of 61 to 69 years although the age range in the literature varies from 12 to 93 years [3–6]. The commonest clinical features are vaginal bleeding, abnormal vaginal cytology and polypoidal cervical mass [3–6]. However, the presenting feature in our case was a large abdomino-pelvic mass.
MMMT are biphasic tumors that consist of an admixture of malignant epithelial and mesenchymal components. The epithelial component represents a variety of different histological sub-types, alone or in combination, which include squamous cell carcinoma, basaloid squamous carcinoma, adenocarcinoma, adeno-squamous carcinoma, adenoid-basal carcinoma, adenoid-cystic carcinoma and undifferentiated carcinoma [3–5]. The sarcomatous component may be homologous (fibroblasts and smooth muscle) or heterologous (cartilage, striated muscle, bone etc). On immunohistochemical examination, both epithelial and sarcomatous components of MMMT may show positivity for broad spectrum cytokeratins, high molecular weight cytokeratin, low molecular weight cytokeratin and epithelial membrane antigen. Sarcomatous components may be positive for vimentin, desmin, muscle specific actin (MSA) and smooth muscle-specific actin (SMA) .
These tumors must be differentiated from other tumors on histopathology. Our case illustrates the varied pattern of MMMT and its tendency to mimic ESS. The islands of squamous differentiation were the clue to the diagnosis, as they are not seen in ESS. Extrauterine ESS arising in the cervix is extremely rare with only three reported cases available in the English literature . These tumors usually arise in the endocervical polyp and histologically resemble ESS of the uterus. ESS are classically positive for CD10 which overlaps with CD 10 positivity in some cases of MMMT  as seen in our case. Other tumors that may mimic MMMT and should be differentiated from it are sarcomatoid carcinoma and mullerian adenosarcoma. In sarcomatoid carcinoma, the carcinomatous component frequently merges with the sarcomatous, as opposed to the sharp distinction seen in MMMT. Mullerian adenosarcoma is relatively easy to differentiate from MMMT, as the epithelial component in the former is benign.
Grayson et al.,  studied human papillomavirus (HPV) status in eight patients with cervical MMMT. In all cases, HPV-DNA was detected by polymerase chain reaction. Interestingly, using in-situ hybridization technique they demonstrated HPV-16 DNA in the nuclei of both epithelial and sarcomatous components in three cases. This observation supports a metaplastic theory of histogenesis of these tumors.
Clement et al.,  reported the largest single series of nine cases of cervical MMMT. They suggested that compared to its uterine counterpart, cervical MMMT is more often confined to the uterus at presentation, frequently has non-glandular epithelial component and may have better prognosis. Due to rarity of this tumor, no evidence based management guidelines are available. Surgery is the principal modality of treatment. Although adjuvant chemotherapy and/or radiotherapy have been used, their role is not well-defined. Radical radiotherapy with or without chemotherapy is recommended for locally advanced disease. Patients with metastatic disease are treated with palliative chemotherapy. Commonly used chemotherapeutic agents are cisplatin, doxorubicin, ifosphamide or cyclophosphamide. The clinical behavior of these tumors is dominated by the carcinomatous component . In our case, only the epithelial squamous component was seen at recurrence, which was successfully treated by radiotherapy that is also the treatment of choice for cervical squamous cell carcinoma.
Cervical malignant mixed mullerian tumors are rare malignancies that may at times present diagnostic difficulties to the clinician. They are best treated by surgery with or without adjuvant radiation and/or chemotherapy. Accurate diagnosis is essential for appropriate treatment and prognosticating the disease.
The authors acknowledge that the written consent was obtained from the patient for publication of this case report.
- Ferriera HP: A case of mixed mesodermal tumor of the uterine cervix. J Obstet Gynaecol Br Emp. 1951, 58: 446-448.View ArticleGoogle Scholar
- Wright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, Gibb RK: Cervical sarcomas: An analysis of incidence and outcome. Gynecol Oncol. 2005, 99: 348-351. 10.1016/j.ygyno.2005.06.021.View ArticlePubMedGoogle Scholar
- Grayson W, Taylor LF, Cooper K: Carcinosarcoma of uterine cervix: a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Am J Surg Pathol. 2001, 25: 338-347.View ArticlePubMedGoogle Scholar
- Abell MR, Ramirez JA: Sarcomas and Carcinosarcomas of the uterine cervix. Cancer. 1973, 31: 1176-1192. 10.1002/1097-0142(197305)31:5<1176::AID-CNCR2820310521>3.0.CO;2-K.View ArticlePubMedGoogle Scholar
- Clement PB, Zubovits JT, Young RH, Scully RE: Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol. 1998, 17: 211-222.View ArticlePubMedGoogle Scholar
- Sharma NK, Sorosky JI, Bender D, Fletcher MS, Sood AK: Malignant mixed mullerian tumor (MMMT) of the cervix. Gynecol Oncol. 2005, 97: 442-445. 10.1016/j.ygyno.2005.01.022.View ArticlePubMedGoogle Scholar
- Mikami Y, Hata S, Kivokawa T, Manabe T: Expression of CD10 in malignant mullerian mixed tumors and adenosarcoma: an immunohistochemical study. Mod Pathol. 2002, 15: 923-930. 10.1097/01.MP.0000026058.33869.DB.View ArticlePubMedGoogle Scholar
- Costa MJ, Guinee D: CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed mullerian tumors) supports a dominant role of the carcinomatous component. Appl Immunohistochem Mol Morphol. 2000, 8: 293-299.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.